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ABSTRACT
Objective: To explore whether awareness versus
unawareness of thyroid dysfunction, diabetes mellitus
or hypertension is associated with self-rated health.
Design: Large-scale, cross-sectional population-based
study. The association between thyroid function,
diabetes mellitus and blood pressure and self-rated
health was explored by multiple logistic regression
analysis.
Setting: The second survey of the Nord-Trøndelag
Health Study, HUNT2, 1995–1997.
Participants: 33 734 persons aged 40–70 years.
Primary outcome measures: Logistic regression
was used to estimate ORs for good self-rated health as
a function of thyroid status, diabetes mellitus status
and blood pressure status.
Results: Persons aware of their hypothyroidism,
diabetes mellitus or hypertension reported poorer self-
rated health than individuals without such conditions.
Women with unknown and subclinical hypothyroidism
reported better self-rated health than women with
normal thyroid status. In women and men, unknown
and probable diabetes as well as unknown mild/
moderate hypertension was not associated with poorer
health. Furthermore, persons with unknown severe
hypertension reported better health than normotensive
persons.
Conclusions: People with undiagnosed but prevalent
hypothyroidism, diabetes mellitus and hypertension
often have good self-rated health, while when aware of
their diagnoses, they report reduced self-rated health.
Use of screening, more sensitive tests and widened
diagnostic criteria might have a negative effect on
perceived health in the population.
INTRODUCTION
Guidelines for prevention and treatment
have been developed for most high-prevalent
diseases in western countries aiming for a
reduction of morbidity and mortality by
interventions mainly in primary healthcare
(PHC).
In society, there seems to be an increasing
conviction of achievable zero vision regarding
risks and diseases. Part of the strategy is to
detect risk factors and prediseases in even
earlier stages. From a secondary or tertiary
healthcare level, this might seem reasonable
since intervention on many individuals with
speciﬁc risk factors presumably can prevent or
delay disease or progression of disease.
Furthermore, health authorities and hospital
clinicians regularly raise concern of the lack of
detection of risk factors, of subclinical condi-
tions and of achieving treatment goals.1–7
Norwegian studies have shown that guidelines
are often difﬁcult to implement and adhere to
in PHC.8 9 According to guidelines, most indi-
viduals would be deﬁned as at risk and
resources needed to handle this appropriately
could destabilise the entire healthcare
system.10–12 An American review pointed out
knowledge, attitude and behaviour as barriers
to physician adherence to clinical guidelines.13
In an already complex and busy PHC setting,
one might expect that resources used for
disease prevention and case ﬁnding have to
compete with resources for handling acknowl-
edged disease. Also, physicians might want to
avoid increasing disease-related burden for
patients, in line with the old wisdom: “primum
non nocere”.14 Thus, the risk and disease zero
visions in society and among politicians are
seldom shared by PHC professionals.
When guidelines, mainly based on research
from high-risk hospital populations, are
applied on low-risk populations in PHC, more
healthy individuals are identiﬁed as being at
risk or are given diagnoses. Also, the widened
inclusion criteria for diagnoses in general and
Strengths and limitations of this study
▪ Sample from a large-scale general population.
▪ High-prevalent diseases under study; ensuring
statistical power in subgroup analyses.
▪ Study mainly based on self-reported data.
▪ Cross-sectional study; susceptibility to con-
founding and impossibility to assume causal
relationships.
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use of more sensitive tests contribute to deﬁne more indi-
viduals at risk or as unhealthy.15 The possible undesirable
outcomes of such strategies remain unclear.
Self-rated health (SRH) is a valid and widely used
measure of general health in epidemiological
research.16–19 It is associated with several clinical condi-
tions often seen in PHC, with recovery,20–23 and is found
to predict morbidity, sick leave and disability pension,24 25
as well as mortality.26–28 The majority of studies describ-
ing an association between labelling of disease per se and
SRH have focused on arterial hypertension.29–32
However, one study has indicated reduced SRH among
individuals labelled with thyroid dysfunctions.33
The aim of this study was to investigate whether
persons’ awareness versus unawareness of thyroid
dysfunction, diabetes mellitus or hypertension was asso-
ciated with their SRH, as reported in a population-based
health study in Norway.
METHODS
Study population
The data sample in this study stems from the second wave
of the Nord-Trøndelag Health Study (HUNT2) con-
ducted in 1995–1997 in the county of Nord-Trøndelag,
Norway. All individuals aged 20 years and older, living in
the county, were invited (94 194 individuals). In all,
66.7% of men (n=30 860) and 75.5% of women
(n=35 280) participated. The survey consisted of ques-
tionnaires and measurements, and has previously been
described in detail.34 35 In our study, we included answers
from the main questionnaire and the baseline measure-
ments for persons aged 40–70 years. The age span was
chosen because thyroid stimulating hormone (TSH) was
analysed in all women and in 50% of men at this age, of a
rather low disease burden in people younger than
40 years and of a lower attendance rate under and above
this age span. A total of 24 950 individuals had TSH mea-
surements and answered thyroid questions and thus were
eligible for analysis on thyroid dysfunction, while in the
analysis of diabetes mellitus and blood pressure (BP),
33 734 individuals were included in all.
Self-rated health
The ﬁrst question in the main questionnaire in HUNT2,
answered before attending the examination stations, was
“How is your health at the moment?”, with answer alter-
natives ‘very good’, ‘good’, ‘not so good’ and ‘poor’.
This short version of SRH measure is shown to be a
valid predictor of mortality.18 28 36 37 We dichotomised
the answers into ‘good’ (very good, good) and ‘poor’
(not so good, poor). Dichotomisation of multinomial
SRH is commonly performed, and has been validated by
Manor et al.38
Thyroid function
The participants answered questions on the history of
hypothyroidism and hyperthyroidism, goitre, other
thyroid diseases and treatment with thyroxin, radio-
iodine, surgery or thyreostatic medication.
Serum TSH and free T4 were analysed at the
hormone laboratory, Aker University Hospital, Norway.
The laboratory reference value for TSH, as deﬁned
prior to the survey, was 0.2–4.5 mU/L and for free T4
8–20 pmol/L. If TSH was <0.2 or >4 mU/L, and/or if
the participant reported any thyroid disease, serum free
T4 was also measured.39
Individuals reporting no previous thyroid disease and
having TSH within the reference range were categorised
as ‘no thyroid disease’ and chosen as the reference cat-
egory. No previous thyroid disease combined with TSH
>4.5 mU/L and free T4 <8 pmol/L was deﬁned as
unknown hypothyroidism. No previous thyroid disease
combined with TSH >4.5 mU/L and free T4 8–20
pmol/L was deﬁned as subclinical hypothyroidism.
Individuals reporting hypothyroidism and use of thyr-
oxin were classiﬁed as having known hypothyroidism,
regardless of the TSH and T4 levels. Afﬁrmative answers
to other thyroid-related questions or measures outside
the reference range in the remainders were classiﬁed as
other thyroid dysfunction.
Diabetes mellitus
Diabetes mellitus was assessed through self-report and
blood samples. Serum glucose was analysed at Levanger
Hospital, Norway. Those reporting no diabetes and having
normal glucose levels (<5.5 mmol/L) were classiﬁed as ‘no
diabetes’ and were chosen as the reference category. No
self-reported diabetes and non-fasting glucose >11 mmol/L
was categorised as unknown diabetes, whereas no diabetes
and non-fasting glucose 5.5–11 mmol/L was categorised as
probable diabetes. Self-reported diabetes was classiﬁed as
known diabetes regardless of the glucose level.
Blood pressure
In the questionnaire, participants were asked about the
doctor’s advice after the latest BP measurement prior to
participation in HUNT. The answer categories were: ‘no
follow-up and no medication necessary’, ‘recommended
follow-up examination but not to take medicine’, ‘start
or continue taking medicine for high blood pressure’ or
‘never measured’. At HUNT2, mean systolic and mean
diastolic arterial BP of measurement 2 and 3 was
categorised into normal (systolic (s) BP<140 mmHg and
diastolic (d) BP<90 mmHg), mild hypertension (sBP 140–
159 mmHg and dBP<100 mmHg or sBP<60 mmHg and
dBP 90–99 mmHg), moderate hypertension (sBP 160–
179 mmHg and dBP<109 mmHg or sBP<180 mmHg and
dBP 100–109mmHg) and severe hypertension (sBP>180
mmHg or dBP>110mmHg). We constructed a new
variable to deﬁne normotensive (reference), unknown
mild and moderate hypertensive, unknown severe hyper-
tensive and known hypertensive persons on the basis of
self-report and measures.
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Statistical analysis
The descriptive analyses of the study population were
stratiﬁed by gender, and we used χ2 tests to examine
any difference in proportions of SRH between the inde-
pendent variables. Gender-stratiﬁed multiple logistic
regression was used to estimate OR with 95% CI for
good SRH, as a function of thyroid status, diabetes melli-
tus status and BP status, in separate unadjusted,
age-adjusted and multiadjusted analyses for each
condition.
Age, smoking, alcohol consumption, body mass index
(BMI), working and educational status, and self-reported
limiting long-term illness or injury are associated with
SRH40 and the diseases under study, but most likely not
affected by SRH or the diseases. Hence, these variables
were included, a priori, as confounders in the models.
Age was categorised into age groups 40–49, 50–59 and
60–70 years. Smoking status was categorised into never
smoked daily, previous daily smoker and current daily
smoker. Alcohol units (AU) were deﬁned as number of
glasses of wine, beer or liquor. Those reporting to be
teetotallers or to have alcohol intake less than four times
a month or less than 7 AU/2 weeks were categorised as
low consumers, those reporting drinking ﬁve to eight
times a month or 8–14 AU/2 weeks as moderate consu-
mers and those drinking more often than eight times a
month or more than 14 AU as heavy consumers. BMI
(kg/m2) was calculated of measured height and weight
and categorised according to the WHO deﬁnition:
underweight (18.5 kg/m2), normal weight (18.5–
24.9 kg/m2), overweight (25–29.9 kg/m2) and obese
(>30 kg/m2). People reporting paid-employed or self-
employed work were classiﬁed as working, otherwise as
not working. Educational level was categorised into <10,
10–12 and >12 years. We chose an afﬁrmative answer to
the question “Do you suffer from any long-term illness
or injury (at least one year) of a physical or psycho-
logical nature that impairs your functioning in your
everyday life?” to represent all relevant chronic medical
conditions that could confound the results.
To examine whether the association of the three
disease statuses with SRH differed by categories of the
other independent variables, we used likelihood ratio
tests with p value for statistical interaction. We tested for
multicollinearity between the independent variables by
linear regression. Areas under the receiver operating
characteristic curves (AUC) were calculated to evaluate
the performance of the logistic regression models.
In an additional analysis, the association between SRH
and having had one or more medical consultations
during the past year was investigated by logistic regres-
sion models, stratiﬁed by gender, in the total study popu-
lation and after exclusion of persons with diagnoses
under study.
All analyses were performed with IBM SPSS Statistics
V.20 for Windows.
All participants signed a written informed consent.
RESULTS
In all age categories, a higher proportion of men than
women reported good SRH (p<0.001), and in both
sexes the proportion reporting good SRH declined by
age (p<0.002; table 1). The proportion reporting good
SRH was lower in overweight, obese and underweight
women than in normal weight women (p<0.001). In
men, the proportion reporting good SRH declined
between the normal weight group and the overweight,
obese and underweight groups (p<0.001). In previous
and current female smokers, a lower proportion
reported good SRH compared with non-smokers
(p<0.001). In men, the proportion reporting good SRH
was higher among non-smokers than among previous
and current smokers (p<0.001), whereas there was no
difference between previous and current smokers. The
proportion reporting good SRH was higher in moderate
and heavy alcohol consumers than in low consumers,
increased with education and was higher for participants
in paid work (p<0.001). Underweight men and persons
with ‘any long-term impairment’ had the lowest propor-
tion reporting good SRH of all groups. The proportion
reporting good SRH in the overall HUNT2 Study popu-
lation differed from the proportions reported in persons
without thyroid disease and normotensive persons
(p<0.01), but not from persons without diabetes melli-
tus. However, the absolute differences were small.
In all fully adjusted regression models, the AUC was
0.80. Unadjusted, the AUC ranged from 0.61 to 0.63.
There was no multicollinearity between the independ-
ent variables.
Thyroid function
Thyroid dysfunctions, known and unknown, were more
often observed among women than men (p<0.001; table 1).
Women with known hypothyroidism had a lower OR of
reporting good SRH than women without thyroid disease in
the adjusted analyses. However, women with unknown or
subclinical hypothyroidism had an 84% and 48% higher
OR, respectively, of reporting good SRH compared with the
OR of women without thyroid disease (table 2). The associ-
ation between thyroid function and SRH was basically
unchanged after inclusion of confounder variables.
Corresponding, but non-signiﬁcant, associations were found
among men.
Diabetes mellitus
The prevalence of unknown, probable and known dia-
betes was slightly higher in men than in women
(p<0.001; table 1). Women with known diabetes mellitus
had a lower OR of good SRH than those without dia-
betes in the adjusted analyses, whereas in women with
unknown or possible diabetes mellitus, the ORs of good
SRH were similar to the ORs among persons without
diabetes in the adjusted analyses (table 2). In the
adjusted analyses, the association between unknown and
probable diabetes mellitus with poor SRH, found in the
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crude analyses, disappeared when age was included in
the model in women and men, but also by inclusion of
working status alone in women. In men, the association
of diabetes status with SRH differed by levels of educa-
tion. Among men without higher education (12 years or
less), the ORs of good SRH were as in the main effect
model (table 2). However, in men with higher educa-
tion, the ORs of good SRH were barely signiﬁcantly
lower among men with unknown diabetes (OR 0.29
(95% CI 0.09 to 1.00)) and among men with possible
diabetes (OR 0.79 (95% CI 0.63 to 1.00)) compared
with men without diabetes. Among men with known dia-
betes in this stratum, the OR of good SRH was 0.31
(95% CI 0.17 to 0.54) compared with men without
diabetes.
Blood pressure
The prevalence of unknown mild and moderate hyper-
tension was higher in men than in women (p<0.001).
Unknown severe hypertension and known hypertension
Table 1 Good SRH by sex and characteristics of the study population
Study population (n=33 734)
Women (n=17 514) Men (n=16 220)
n Per cent SRH good (%) n Per cent SRH good (%)
Age group (years)
40–50 7058 40.3 77.6 6517 40.2 81.7
51–60 5709 32.6 64.4 5328 32.8 72.1
61–70 4747 27.1 56.6 4375 27.0 59.6
BMI (kg/m2)
<18.5 6821 0.6 58.4 4804 0.2 42.9
18.5–24.9 7026 39.1 72.8 8694 29.7 75.3
25.0–29.9 3489 40.3 68.5 2635 53.8 73.6
>30 (0.4% missing) 104 20.0 56.5 35 16.3 64.8
Smoking status
Never smoked daily 6973 40.1 70.3 4849 30.1 80.0
Previous daily smoker 4651 26.7 68.0 6105 37.9 69.8
Daily smoker (0.7% missing) 5763 33.1 64.3 5172 32.0 69.1
Alcohol use
None to low intake 14 888 88.7 66.7 11 488 73.2 71.0
Moderate intake 1471 8.8 76.8 2839 18.1 78.7
High intake (3.7% missing) 430 2.6 76.3 1375 8.8 78.3
Educational level (years)
<10 8133 48.5 60.5 5711 36.5 63.1
10–12 5682 33.9 72.8 6615 42.2 76.0
>12 (3.8% missing) 2962 17.7 80.0 3339 21.3 84.7
Employed
Yes 11 539 67.2 77.1 12 309 77.1 79.9
No (1.8% missing) 5627 32.8 49.0 3665 22.9 49.2
Any long-term impairment
No 10 348 59.1 85.9 9912 63.0 88.7
Yes (4.1% missing) 6275 35.8 39.8 5829 37.0 46.0
Thyroid function
No thyroid disease 14 373 86.2 68.7 7804 94.3 72.1
Unknown hypothyroidism 107 0.6 78.5 16 0.2 68.8
Subclinical hypothyroidism 466 2.8 75.0 150 1.8 66.4
Known hypothyroidism 858 5.1 48.9 124 1.5 58.1
Other thyroid dysfunction (1.3% missing) 872 5.2 61.4 180 2.2 56.2
Diabetes mellitus
No diabetes 11 279 64.6 69.4 9196 56.9 74.6
Unknown diabetes 46 0.3 52.2 88 0.5 67.8
Probable diabetes 5728 32.8 65.9 6392 39.6 71.5
Known diabetes (0.4% missing) 395 2.3 43.1 482 3.0 49.5
Blood pressure status
Normotensive 9135 52.6 72.4 6858 42.7 77.5
Unknown mild/moderate hypertension 4473 25.8 67.9 5343 33.3 74.7
Unknown severe hypertension 403 2.4 70.7 349 2.2 73.8
Known hypertension (0.9% missing) 3327 19.2 54.0 3498 21.8 59.6
Overall study population, HUNT2 34 332 97.3 70.3 30 378 98.4 74.9
BMI, body mass index; HUNT, Nord-Trøndelag Health Study; SRH, self-rated health.
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Table 2 The association between self-rated health and thyroid function, diabetes mellitus and blood pressure
Women, OR (95% CI) Men, OR (95% CI)
n Crude Age adjusted Multiple adjusted n Crude Age adjusted Multiple adjusted
Thyroid function
No thyroid dysfunction 12 476 1.00 1.00 1.00 7045 1.00 1.00 1.00
Unknown hypothyroidism 92 1.66 (1.05 to 2.64) 2.00 (1.25 to 3.19) 1.84 (1.02 to 3.33) 14 0.85 (0.30 to 2.45) 0.92 (0.31 to 2.72) 1.28 (0.35 to 4.65)
Subclinical hypothyroidism 394 1.37 (1.10 to 1.69) 1.49 (1.20 to 1.85) 1.48 (1.13 to 1.94) 128 0.77 (0.54 to 1.08) 0.88 (0.62 to 1.24) 1.13 (0.72 to 1.76)
Known hypothyroidism 718 0.44 (0.38 to 0.50) 0.48 (0.41 to 0.55) 0.49 (0.41 to 0.59) 107 0.54 (0.37 to 0.77) 0.63 (0.43 to 0.91) 0.69 (0.44 to 1.09)
Other thyroid dysfunction 729 0.72 (0.63 to 0.83) 0.77 (0.67 to 0.89) 0.77 (0.65 to 0.93) 163 0.50 (0.37 to 0.67) 0.52 (0.38 to 0.71) 0.58 (0.41 to 0.84)
Diabetes mellitus
No diabetes 9946 1.00 1.00 1.00 8464 1.00 1.00 1.00
Unknown diabetes 39 0.48 (0.27 to 0.86) 0.61 (0.34 to 1.10) 0.66 (0.32 to 1.37) 82 0.72 (0.46 to 1.13) 0.88 (0.55 to 1.39) 1.03 (0.59 to 1.81)
Probable diabetes 4797 0.85 (0.80 to 0.91) 0.94 (0.88 to 1.01) 1.01 (0.92 to 1.10) 5759 0.86 (0.80 to 0.92) 0.94 (0.88 to 1.01) 0.99 (0.91 to 1.08)
Known diabetes 318 0.33 (0.27 to 0.41) 0.42 (0.34 to 0.51) 0.53 (0.41 to 0.69) 395 0.33 (0.28 to 0.40) 0.42 (0.35 to 0.51) 0.55 (0.43 to 0.70)
Blood pressure
No hypertension 8180 1.00 1.00 1.00 6378 1.00 1.00 1.00
Unknown mild/moderate
hypertension
3787 0.81 (0.75 to 0.87) 1.01 (0.93 to 1.09) 1.10 (0.99 to 1.22) 4837 0.86 (0.79 to 0.93) 1.01 (0.92 to 1.10) 1.01 (0.92 to 1.12)
Unknown severe
hypertension
325 0.92 (0.74 to 1.15) 1.34 (1.08 to 1.68) 1.52 (1.14 to 2.02) 308 0.85 (0.77 to 1.08) 1.27 (0.99 to 1.62) 1.48 (1.09 to 2.02)
Known hypertension 2745 0.45 (0.41 to 0.49) 0.59 (0.54 to 0.65) 0.69 (0.61 to 0.77) 3118 0.43 (0.39 to 0.47) 0.54 (0.50 to 0.60) 0.64 (0.57 to 0.72)
OR of good self-rated health and 95% CIs, crude, age adjusted, and adjusted for age, other long-term illness or injury that impairs function in everyday life, smoking habits, alcohol use,
educational level, work status and body mass index. Cases with missing data were excluded from the analyses.
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were equally distributed between women and men
(table 1). Women with known hypertension had a lower
OR of reporting good SRH than normotensive women
in the adjusted analyses. The ﬁgures were similar in men
(table 2). In contrast, compared with normotensive
women, those with unknown severe hypertension had a
52% higher OR of reporting good SRH, with similar
ﬁgures in men. Persons with unknown mild and moder-
ate hypertension reported good SRH, similar to the
normotensive ones. Adjusted for age, the association
between unknown mild and moderate hypertension and
poor SRH disappeared simultaneously; unknown severe
hypertension became associated with good SRH in
women. In men, age had to be added along with either
education or working status to achieve the latter
association.
Additional analyses
Women with poor SRH had more than six times the OR
of those with good SRH to have had a medical consult-
ation during the last year; OR 6.29 (95% CI 5.47 to
7.22). For men, the corresponding OR was 5.53 (95% CI
4.86 to 6.29). After exclusion of persons with diagnosed
thyroid disease, diabetes mellitus, known hypertension
and ‘any long-term disease’, the corresponding OR was
3.71 (95% CI 2.90 to 4.73), with similar ﬁgures in men.
DISCUSSION
This large population-based study showed that persons
with known thyroid dysfunction, diabetes mellitus and
hypertension were less likely to report good SRH than
those without such conditions. Less expected, persons
with unknown and subclinical hypothyroidism were
more likely to report good SRH than those without
thyroid disease. Similarly, those with unknown severe
hypertension were more likely to report good SRH, com-
pared with persons with normal BP. In general, persons
with unknown diabetes and unknown mild/moderate
hypertension reported good health, just like the refer-
ence group.
In general, of the confounders, age seemed to inﬂu-
ence the association between disease status and SRH
most when adjusted for. Age was found to explain the
association of poor SRH with unknown and probable
diabetes, and with unknown mild and moderate hyper-
tension. In women, age even contributed to an associ-
ation between unknown severe hypertension and good
SRH. There seemed to be a linear decrease by age cat-
egories in the association with good SRH. The way age is
known to be related to disease and SRH makes these
ﬁndings reasonable.
Although a qualitative and quantitative measure of
association, the estimated ORs in our study will, if inter-
preted as relative risks, overestimate the case, because
the prevalence of good SRH is high in all groups.41
The main strengths of this study were: the number of
participants, that the diseases we studied were high
prevalent and that we could assume representativeness
to the general population regarding the variables
included. It is known that individuals with a high
burden of symptoms are less likely to attend surveys, but
so far there has been little evidence that non-
participation on this basis introduces substantial bias in
associational studies.42 We studied diseases with a gener-
ally low symptom burden and expect selection bias to be
negligible.
The main limitation was possibly that we relied on self-
reported data on dependent and independent variables.
The validity of self-reported measures relevant for this
study is questionable. However, in case of any misclassiﬁ-
cation, it should be non-differential, thus should only
cause an underestimation of the associations found.
There is always a possibility of residual confounding in
non-randomised study designs, and owing to the obser-
vational, cross-sectional design, we cannot assume a
causal relationship.
Bias due to differential detection of disease in the
study population could lead to a type 1 error.
Hypothyroidism and diabetes mellitus are often asso-
ciated with vague symptoms such as tiredness and weak-
ness. These symptoms are strongly associated with
reduced SRH.43 It is most likely that presenting such
symptoms for the general practitioner (GP) would result
in measurements of TSH, free T4 and serum glucose,
thus revealing any related dysfunction. Low self-
perceived health increases the probability of visiting a
GP.44 Social security covers most of the costs related to
clinical measurements and blood sampling in Norway;
thus, we expect GPs to have a low threshold to measure
thyroid function, BP or glucose levels. People who do
not consult their GP will not have diseases with mild or
no symptoms diagnosed, and their personality could be
characterised by a less worrying and more optimistic atti-
tude to health being reﬂected in better SRH.45
On the other hand, the association between known
disease and poor SRH could in fact be explained physio-
logically due to the pathological effect of disease. Lack
of a corresponding association between ignored, but
prevalent, disease and poor SRH is not in line with this
hypothesis, raising the question of a possible adverse
effect of disease labelling. However, confounding by
severity of disease cannot be ruled out.
Owing to the low number of persons having unknown
hypothyroidism and diabetes mellitus, the results should
be interpreted with caution. On the other hand, there
were high numbers in the subclinical and probable
groups, and analyses of these groups did not show any
associations with poor SRH, also raising questions of a
possible disease labelling effect.
The fact that the HUNT2 survey was carried out nearly
20 years ago raises a question of generalisability to today’s
population. Stability of SRH over time has not been inves-
tigated in our study population, although it has been
investigated among adolescents.46 We do not expect the
association between low burden and subclinical disease
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with SRH to be time dependent to the extent that it
would change our results considerably. Neither do we
expect the changes in prevalence of most explanatory
variables to inﬂuence the associations found.
Consistent ﬁndings regarding unknown, subclinical
and probable disease versus known disease could indi-
cate a potential adverse effect of disease labelling.
Although early detection of disease is protective on mor-
bidity and mortality for many diseases, low SRH is also
shown to be associated with morbidity and mortality.25–27
This is an important aspect in the debate of presympto-
matic case ﬁnding.
The BMJ’s Too Much Medicine campaign aims to
highlight the threat to human health posed by overdiag-
nosis and the waste of resources on unnecessary care
(http://www.bmj.com/too-much-medicine). American
data have shown that the majority of all healthcare
includes preference-sensitive and supply-sensitive ser-
vices. The extent of these services varies greatly without
necessarily leading to better health.47 48 A great deal of
activity in such services is based on identifying subclin-
ical disease. The negative health effect this might have,
modulated through reduced SRH, can explain why
population mortality is not reduced in areas with a high
frequency of diagnoses.
Public and academic debates are often characterised
by the conviction that all medical treatment is efﬁcient.
Wennberg49 showed that a relatively small proportion of
all medical treatment is indisputably good for health.
The concern for unrevealed risk factors and subclinical
conditions might lead to unnecessary costly healthcare
interventions, increase supply-sensitive services without
positive health effect and have a negative inﬂuence on
people’s general and self-perceived health causing more
harm than good.15
Of ethical reasons, the possible causal effect of disease
labelling on SRH is impossible to assess in a randomised
controlled trial. Our study emphasises the need for
more prospective research to investigate the potential
health effects of disease labelling and early diagnosis.
CONCLUSION
Our data suggest that early identiﬁcation of disease may
imply a negative effect on SRH, and to the extent that
SRH has been associated with greater mortality, this may
lead to harm. However, as it is also known that diseases
such as diabetes and hypertension also lead to increased
mortality when detected after cardiovascular and meta-
bolic complications have developed, it remains to be seen
whether an early identiﬁcation or a late detection strategy
would provide optimal health for the population.
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